Shenzhen Particle Forest Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Shenzhen Particle Forest Technology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 7 (Machinery) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include VIAROY and LZFORES. The owner is based in Shenzhen.
Room 122, Building 2, No. 147, Jinglong Zhonghuan Road,
Shangfen Community, Minzhi Street, Longhua District,
Shenzhen 518129 , CN
Showing of trademarks Trademarks
Trademark Classifications
Shenzhen Particle Forest Technology Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does Shenzhen Particle Forest Technology Co., Ltd. have?
Shenzhen Particle Forest Technology Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Shenzhen Particle Forest Technology Co., Ltd. file in?
Shenzhen Particle Forest Technology Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 7 (Machinery), Class 10 (Medical Apparatus). Class 7 covers machines and machine tools; motors and engines; machine coupling and transmission components.
What are Shenzhen Particle Forest Technology Co., Ltd.'s most well-known trademarks?
Shenzhen Particle Forest Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as VIAROY and LZFORES. These are among 2 currently registered trademarks in the portfolio.
What is Shenzhen Particle Forest Technology Co., Ltd.'s trademark registration success rate?
Shenzhen Particle Forest Technology Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.